AR079680A1 - Composiciones y metodos para el cuidado bucal - Google Patents
Composiciones y metodos para el cuidado bucalInfo
- Publication number
- AR079680A1 AR079680A1 ARP100104852A ARP100104852A AR079680A1 AR 079680 A1 AR079680 A1 AR 079680A1 AR P100104852 A ARP100104852 A AR P100104852A AR P100104852 A ARP100104852 A AR P100104852A AR 079680 A1 AR079680 A1 AR 079680A1
- Authority
- AR
- Argentina
- Prior art keywords
- loss
- mmp
- isopropyl
- combinations
- well
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/32—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C271/38—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/96—Esters of carbonic or haloformic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
Abstract
Reivindicacion 1: Un método para el tratamiento de un estado de salud asociado con la expresion aberrante de la MMP-13, caracterizado porque comprende administrar a un paciente una cantidad efectiva desde el punto de vista terapéutico de NDM de extracto de arándano rojo, ácido acetil ceto beta-boswélico, resveratrol, 2-isopropil-5-metilciclohexil 2-hidroxifenilcarbamato, 4-acetamidofenil 2-isopropil-5-metilciclohexil carbonato, así como combinaciones de dos o más de los mismos. Reivindicacion 2: El método de acuerdo con la Reivindicacion 1, caracterizado porque el estado de salud asociado con la expresion aberrante de la MMP-13 se selecciona del grupo que consiste de degradacion de la matriz extracelular, pérdida de acoplamiento de uno o más dientes, pérdida dental, movilidad dental, formacion de surcos, pérdida osea, así como combinaciones de dos o más de los mismos. Reivindicacion 10: La composicion de acuerdo con cualquiera de las Reivindicaciones 4 a 9, caracterizada porque la composicion es un dentífrico.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28835909P | 2009-12-21 | 2009-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR079680A1 true AR079680A1 (es) | 2012-02-15 |
Family
ID=43827777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP100104852A AR079680A1 (es) | 2009-12-21 | 2010-12-21 | Composiciones y metodos para el cuidado bucal |
Country Status (15)
Country | Link |
---|---|
US (2) | US8883179B2 (es) |
EP (1) | EP2515895B1 (es) |
JP (1) | JP5718360B2 (es) |
CN (1) | CN102781439B (es) |
AR (1) | AR079680A1 (es) |
AU (1) | AU2010339713B2 (es) |
BR (1) | BR112012015401A2 (es) |
CA (1) | CA2780821C (es) |
CO (1) | CO6481010A2 (es) |
MX (1) | MX2012006018A (es) |
MY (1) | MY154024A (es) |
RU (1) | RU2553500C2 (es) |
TW (1) | TW201141536A (es) |
WO (1) | WO2011084781A2 (es) |
ZA (1) | ZA201204530B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106420439A (zh) * | 2016-08-28 | 2017-02-22 | 冯涵丽 | 除菌牙膏 |
CN108653174A (zh) * | 2018-07-11 | 2018-10-16 | 杭州纳美智康科技有限公司 | 一种含银耳多糖的牙膏及其制备方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0939629A4 (en) * | 1996-07-22 | 2002-07-17 | Monsanto Co | THIOL-SULFONAMIDES AS METALLOPROTEINAS INHIBITORS |
NZ334258A (en) | 1996-08-28 | 2000-11-24 | Procter & Gamble | Phosphinic acid amides as matrix metalloprotease inhibitors |
WO1998015525A1 (fr) | 1996-10-07 | 1998-04-16 | Sumitomo Pharmaceuticals Co., Ltd. | Acides hydroxamiques |
US5840322A (en) * | 1996-12-19 | 1998-11-24 | Ramot-University Authority For Applied Research & Industrial Devel. Ltd. | Anti-oral-microbial adhesion fraction derived from vaccinium |
NZ502309A (en) * | 1997-08-08 | 2002-02-01 | Pfizer Prod Inc | Aryloxyarylsulfonylamino hydroxamic acid derivatives and pharmaceutical use |
JPH11139947A (ja) * | 1997-11-11 | 1999-05-25 | Sunstar Inc | マトリックスメタロプロテアーゼ阻害剤含有口腔用組成物 |
FR2778337B1 (fr) | 1998-05-05 | 2001-08-31 | Inst Nat Sante Rech Med | Antagonistes des ligands du recepteur des arylhydrocarbures |
US6716883B1 (en) * | 1998-12-24 | 2004-04-06 | 1333366 Ontario Inc. | Composition useful to treat periodontal disease |
GB9916562D0 (en) * | 1999-07-14 | 1999-09-15 | Pharmacia & Upjohn Spa | 3-Arylsulfonyl-2-(substituted-methyl) propanoic acid derivatives as matrix metalloproteinase inhibitora |
CA2312505A1 (en) * | 2000-06-27 | 2001-12-27 | 1333366 Ontario Inc. | Resveratrol compositions for topical use in the treatment of oral diseases and infections |
WO2005025527A1 (de) * | 2003-09-09 | 2005-03-24 | Dsm Ip Assets B.V. | Oral wirkendes im wesentlichen wasserfreies topisches mittel enthaltend ein oder mehrere oxidationsempfindliche stoffe |
CA2615444A1 (en) | 2005-07-15 | 2007-01-25 | Donald J. Baker | Compositions and methods for treating and preventing inflammatory and/or degenerative processes in humans and other animals |
DE202006008905U1 (de) * | 2006-06-02 | 2006-08-17 | Fritz, Uwe | Zusatzstoff für Lebensmittel |
EP2626077A3 (en) * | 2007-03-19 | 2013-11-20 | Metaproteomics, LLC | Compositions for promoting bone and joint health |
CN101686725A (zh) * | 2007-04-03 | 2010-03-31 | 刚迦·拉贾·高卡拉贾 | 消炎和抗氧化协同作用的膳食补充组合物 |
EP2192910A1 (en) * | 2007-10-01 | 2010-06-09 | Colgate-Palmolive Company | Oral compositions containing botanical extracts |
EP2307357A1 (en) * | 2008-05-30 | 2011-04-13 | Symrise AG | L-menthyl-n-(2-hydroxyphenyl)carbamate |
MY170956A (en) * | 2009-04-01 | 2019-09-20 | Colgate Palmolive Co | Menthol-derivative compounds and use thereof as oral and systemic active agents |
-
2010
- 2010-12-20 TW TW099144650A patent/TW201141536A/zh unknown
- 2010-12-21 MX MX2012006018A patent/MX2012006018A/es active IP Right Grant
- 2010-12-21 EP EP10803428.1A patent/EP2515895B1/en active Active
- 2010-12-21 AU AU2010339713A patent/AU2010339713B2/en not_active Ceased
- 2010-12-21 US US13/518,103 patent/US8883179B2/en active Active
- 2010-12-21 CA CA2780821A patent/CA2780821C/en not_active Expired - Fee Related
- 2010-12-21 AR ARP100104852A patent/AR079680A1/es unknown
- 2010-12-21 CN CN201080058799.XA patent/CN102781439B/zh not_active Expired - Fee Related
- 2010-12-21 RU RU2012130956/14A patent/RU2553500C2/ru not_active IP Right Cessation
- 2010-12-21 BR BR112012015401A patent/BR112012015401A2/pt not_active IP Right Cessation
- 2010-12-21 MY MYPI2012002279A patent/MY154024A/en unknown
- 2010-12-21 WO PCT/US2010/061491 patent/WO2011084781A2/en active Application Filing
- 2010-12-21 JP JP2012546139A patent/JP5718360B2/ja not_active Expired - Fee Related
-
2012
- 2012-06-05 CO CO12094637A patent/CO6481010A2/es active IP Right Grant
- 2012-06-19 ZA ZA2012/04530A patent/ZA201204530B/en unknown
-
2014
- 2014-10-02 US US14/505,496 patent/US9320696B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2780821A1 (en) | 2011-07-14 |
MX2012006018A (es) | 2012-06-19 |
TW201141536A (en) | 2011-12-01 |
AU2010339713B2 (en) | 2013-11-07 |
CO6481010A2 (es) | 2012-07-16 |
JP2013515075A (ja) | 2013-05-02 |
US20150086490A1 (en) | 2015-03-26 |
US20120294915A1 (en) | 2012-11-22 |
CN102781439B (zh) | 2015-11-25 |
US8883179B2 (en) | 2014-11-11 |
EP2515895B1 (en) | 2018-02-14 |
EP2515895A2 (en) | 2012-10-31 |
US9320696B2 (en) | 2016-04-26 |
ZA201204530B (en) | 2014-11-26 |
CN102781439A (zh) | 2012-11-14 |
RU2553500C2 (ru) | 2015-06-20 |
RU2012130956A (ru) | 2014-01-27 |
WO2011084781A3 (en) | 2011-11-10 |
MY154024A (en) | 2015-04-30 |
WO2011084781A2 (en) | 2011-07-14 |
AU2010339713A1 (en) | 2012-06-07 |
BR112012015401A2 (pt) | 2017-03-14 |
JP5718360B2 (ja) | 2015-05-13 |
CA2780821C (en) | 2014-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012013473A2 (pt) | composição para higiene oral e método para o tratamento de uma doença ou condição do tecido mole da cavidade oral | |
HK1123484A1 (en) | Method of using oxidative reductive potential water solution in dental applications | |
CO6571900A2 (es) | Composiciones famaceúticas del compuesto espiro-oxindol para adminsitración tópica y sus usos como agentes terapeúticos | |
AR062522A1 (es) | Tratamiento de desordenes en cartilagos | |
UA104320C2 (ru) | Фармацевтическая композиция на основе митохондриально-адресованного антиоксиданта для применения в медицинской и ветеринарной офтальмологии | |
BRPI0819690B8 (pt) | uso de uma composição compreendendo cisteamina ou cistamina, ou um sal farmaceuticamente aceitável das mesmas | |
DOP2011000047A (es) | Agentes terapeuticos 414 | |
CO6460709A2 (es) | Composiciones borínicas | |
BR112012015750A2 (pt) | composição para higiene oral, método para melhorar o cumprimento de um plano de tratamento pelo paciente com uma composição para higiene oral, e, método para branqueamento de uma superfície dental | |
CL2011002766A1 (es) | Compuestos derivados de carboxamida, inhibidores de calpaina; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades neurodegenerativas, alzahimer, dolor, entre otras. | |
MX2017004772A (es) | Composiciones y métodos para la administración fisiológica utilizando cannabidiol. | |
MY192494A (en) | Vaginal composition and use thereof | |
IN2014DN10291A (es) | ||
CO6592015A2 (es) | Métodos y composiciones para reducir o prevenir la cladificación vascular durante el tratamiento de diálisis peritoneal | |
BR112015019802A2 (pt) | formulações farmacêuticas de nitrito e usos das mesmas | |
BR122021012549B8 (pt) | Composição de dissolução oral de melatonina com agente acidificante que torna melatonina solúvel em saliva | |
AR079680A1 (es) | Composiciones y metodos para el cuidado bucal | |
MD3905G2 (ro) | Remediu medicamentos cu acţiune prelungită sub formă de gel pentru tratamentul afecţiunilor parodonţiului (variante) | |
PE20130308A1 (es) | Metodos para tratar infecciones bacterianas recurrentes | |
BR112015010808A2 (pt) | pastilha medicamentosa à base de ibuprofeno sódico di-hidratado | |
NZ597675A (en) | Medicament for the long term nsaid use | |
WO2014145636A3 (en) | System and method for treatment of endodontic/periodontic conditions | |
PE20080455A1 (es) | Mirtazapina para el tratamiento de dolor neuropatico | |
MY186889A (en) | Oral care composition | |
EA201791448A1 (ru) | Анестетик на основе тетракаина |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |